The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization /
| Main Author: | Thaul, Susan (Author) |
|---|---|
| Format: | Government Document Database |
| Language: | English |
| Published: |
[Washington, D.C.] :
Congressional Research Service,
2020-
|
| Edition: | [Library of Congress public edition]. |
| Series: | CRS report ;
RL33914. |
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo141884 |
Similar Items
Prescription Drug User Fee Act (PDUFA) : 2012 reauthorization as PDUFA V /
by: Thaul, Susan
Published: (2019)
by: Thaul, Susan
Published: (2019)
Prescription Drug User Fee Act (PDUFA) : 2017 reauthorization as PDUFA VI /
by: Dabrowska, Agata, et al.
Published: (2018)
by: Dabrowska, Agata, et al.
Published: (2018)
The Prescription Drug User Fee Act : structure and reauthorization issues /
by: Vogt, Donna U., et al.
Published: (2020)
by: Vogt, Donna U., et al.
Published: (2020)
FY ... PDUFA financial report required by the Prescription Drug User Fee Act of 1992 as amended by the Food and Drug Administration Modernization Act of 1997.
Published: (1999)
Published: (1999)
Annual financial report, Prescription Drug User Fee Act of 1992 : ... report to Congress.
Published: (1998)
Published: (1998)
Annual performance report, Prescription Drug User Fee Act of 1992 fiscal year : ... report to Congress /
Published: (1997)
Published: (1997)
FY ... performance report to Congress for the Prescription Drug User Fee Act of 1992 as amended by the Food and Drug Administration Modernization Act of 1997 /
Published: (1998)
Published: (1998)
Prescription drugs : FDA has met most performance goals for reviewing applications : report to congressional requesters.
Published: (2012)
Published: (2012)
PDUFA pilot project : proprietary name review.
Published: (2008)
Published: (2008)
User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992.
Published: (1992)
Published: (1992)
PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
Published: (2012)
Published: (2012)
Reauthorization of PDUFA : what it means for jobs, innovation, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 1, 2012.
Published: (2012)
Published: (2012)
Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)
Published: (2018)
PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
Published: (2012)
Published: (2012)
FY ... performance report to the President and the Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002.
Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities : report to the chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate /
Published: (2002)
Published: (2002)
Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities.
Published: (2002)
Published: (2002)
Controlling drug expenditure in Canada : the Ontario experience /
by: Gorecki, Paul K.
Published: (1992)
by: Gorecki, Paul K.
Published: (1992)
Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.
Published: (2018)
Published: (2018)
Texas fees : putting a price on state services.
Published: (1987)
Published: (1987)
FDA drug approval : application review times largely reflect FDA goals : report to congressional requesters.
Published: (2020)
Published: (2020)
Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)
by: Drake, Donald, 1935-
Published: (1993)
Information on the annual fee on branded prescription drug companies under the Affordable Care Act.
Published: (2014)
Published: (2014)
Implementing user fees in the Food and Drug Administration : a case study.
Published: (1990)
Published: (1990)
Prescription drugs : out-of-pocket expenses and unmet need relative to family income, 2002 /
by: Crimmel, Beth Levin
Published: (2005)
by: Crimmel, Beth Levin
Published: (2005)
Prescription drug user fee act of 1992 : effects on bringing new drugs to market /
by: Cantor, David J.
Published: (1997)
by: Cantor, David J.
Published: (1997)
Federal user fees : fee design options and implications for managing revenue instability : report to the Chairman, Committee on the Budget, House of Representatives.
Published: (2013)
Published: (2013)
Animal drug user fee programs /
by: Dabrowska, Agata, et al.
Published: (2018)
by: Dabrowska, Agata, et al.
Published: (2018)
Performance report to Congress for the Office of Combination Products as required by the Medical Device User Fee and Modernization Act of 2002 (Online).
Published: (2004)
Published: (2004)
FY ... performance report to the Congress for the Office of Combination Products as amended in the Medical Device User Fee and Modernization Act (Online).
Published: (2004)
Published: (2004)
Proposed FDA user fee acts : Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA) /
by: Thaul, Susan, et al.
Published: (2019)
by: Thaul, Susan, et al.
Published: (2019)
Copayments and the demand for prescription drugs /
by: Esposito, Domenico, 1974-
Published: (2006)
by: Esposito, Domenico, 1974-
Published: (2006)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)
Published: (2008)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)
Published: (2008)
The 2011 Mileage-Based User Fee Symposium /
by: Goodin, Ginger Daniels
Published: (2011)
by: Goodin, Ginger Daniels
Published: (2011)
Federal user fees : fee design characteristics and trade-offs illustrated by USCIS's immigration and naturalization fees : testimony before the Subcommittee on Immigration, Citizenship, Refugees, Border Security, and International Law, Committee on the Judiciary, U.S. House of Representatives /
by: Irving, Susan J.
Published: (2010)
by: Irving, Susan J.
Published: (2010)
Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.
Published: (2008)
Published: (2008)
Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.
Published: (2008)
Published: (2008)
Outpatient prescription medicines : a comparison of expenditures by household-reported condition, 1987 and 2001 /
by: Stagnitti, Marie N.
Published: (2004)
by: Stagnitti, Marie N.
Published: (2004)
FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012.
Published: (2013)
Published: (2013)